We discuss here critical factors in ensuring the success of a viral diagnostic at the point of care. Molecular and immunoassay approaches are reviewed with a focus on their ability to meet the ...
PoC testing is in the market today – it is worth approximately US$11.5 billion annually, with percentage growth in double figures and some three-times faster than the total IVD market. Applications to ...
Changes in healthcare economics are clearly having an impact on point-of-care (POC) diagnostic testing. Market demand for remote testing is driving companies to develop easy-to-use platforms versus ...
Pricing pressure due to reimbursement cuts and limited budgets along with strict regulatory approval process for new point of care product commercialization are factors expected to restrain market ...
DUBLIN, March 17, 2020 /PRNewswire/ -- The "Point of Care Molecular Diagnostics Market by Product and Solution (Assay, Analyzer, Software, Services), Technology (RT-qPCR, INAAT), Application ...
The point of care molecular (POC) diagnostics market is poised for robust growth on the back of the burgeoning prevalence of infectious diseases across the globe. As per the CDC (Centers for Disease ...
Infectious diseases afflict millions of people every year. These hard-hitting viruses can rapidly sweep through populations and, in some cases, whole continents in a matter of weeks. Identifying and ...
Polymerase chain reaction (PCR) tests are one of the most popular diagnostic tools for the detection and diagnosis of viral diseases, such as coronavirus (COVID-19), due to their ability to rapidly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results